
[Image from PharmaJet]
Golden, Colorado-based PharmaJet’s needle-free injection systems are being studied with Covigen, a DNA-based vaccine developed by French-Thai pharmaceutical company BioNet-Asia in collaboration with Melbourne, Australia-based Technovalia. Enrollment for the trial began in June 2021.
Get the full story at our sister site, Drug Delivery Business News.
Filed Under: clinical trials, Drug Delivery, Drug Discovery, Immunology, Infectious Disease